2018 News

Peter Hamer joins SurgaColl as Chief Executive Officer

Alderley Park, UK – 10th December 2018. SurgaColl, a regenerative medicine company, today announced the appointment of Peter Hamer as Chief Executive Officer. Mr. Hamer succeeds Bill Allan as CEO following Bill’s decision to ret...

Maxwellia expand their team with two new appointments

Maxwellia has expanded their team of switch experts with two new appointments following their relocation to the Alderley Park Accelerator.  Maxwellia, the UK’s only ‘prescription to over the counter (OTC)’ medicines c...

Med-Tech companies triumph at the Bionow Awards

The outstanding companies and leaders of the North’s life sciences sector – which is worth more than £13bn to the economy- were honoured last night at the 17th annual Bionow Awards.  More than 300 people attended the aw...

Blueberry Therapeutics Announce Positive Results from a Phase I-II Clinical Trial

Alderley Park, UK, 21stNovember 2018– Blueberry Therapeutics Limited (“Blueberry Therapeutics”), a modern drug discovery and development company committed to the development of innovative new therapies for the treatment of comm...

YProtech receives £400k funding boost

A high value chemistry services company based at Alderley Science Park has secured £400,000 of funding. YProtech (YPT) was founded in 2011. The core of the company's business relates to those operating in the pharmaceutical, biotechno...

From our portfolio

Manchester Imaging

Digital Healthcare Technology

viewview our portfolio

Our Team

Nick Wright

view complete team

Contact us

Tel: 01625 344300